98 related articles for article (PubMed ID: 19542965)
1. Tc-99m pertechnetate/sestamibi imaging in a case of recurrent parathyroid carcinoma with metabolic bone disorder.
Meng Z; Tan J; Zhang M; Dong F; Jia Q; Zhang F
Clin Nucl Med; 2009 Jul; 34(7):479-82. PubMed ID: 19542965
[No Abstract] [Full Text] [Related]
2. [Reversible hyperparathyroid metabolic osteopathy secondary to parathyroid carcinoma].
Serrano J; Verdú J; Martínez A; Antón A; Caballero O
Rev Esp Med Nucl; 1998; 17(1):35-9. PubMed ID: 9609842
[TBL] [Abstract][Full Text] [Related]
3. Detection of metastatic parathyroid carcinoma with Tc-99m sestamibi imaging.
Al-Sobhi S; Ashari LH; Ingemansson S
Clin Nucl Med; 1999 Jan; 24(1):21-3. PubMed ID: 9890488
[TBL] [Abstract][Full Text] [Related]
4. Tc-99m pertechnetate/sestamibi subtraction scan in a case of parathyroid carcinoma.
Singhal T; Jacobs M; Mantil JC
Clin Nucl Med; 2008 Mar; 33(3):196-7. PubMed ID: 18287845
[No Abstract] [Full Text] [Related]
5. Recurrent postoperative parathyroid carcinoma: FDG-PET and sestamibi-SPECT findings.
Neumann DR; Esselstyn CB; Kim EY
J Nucl Med; 1996 Dec; 37(12):2000-1. PubMed ID: 8970522
[TBL] [Abstract][Full Text] [Related]
6. Comparison of parathyroid imaging with technetium-99m-pertechnetate/sestamibi subtraction, double-phase technetium-99m-sestamibi and technetium-99m-sestamibi SPECT.
Chen CC; Holder LE; Scovill WA; Tehan AM; Gann DS
J Nucl Med; 1997 Jun; 38(6):834-9. PubMed ID: 9189125
[TBL] [Abstract][Full Text] [Related]
7. Detection of late chest wall recurrence of breast carcinoma during Tc-99m sestamibi parathyroid scintigraphy.
Conrad GR; Sloan DA; Sinha P
Clin Nucl Med; 2003 May; 28(5):408-9. PubMed ID: 12702942
[No Abstract] [Full Text] [Related]
8. [Primary hyperparathyroidism due to parathyroid carcinoma].
Megino Moreno T; Herranz Antolín S; Bernal Bello D; Alvarez De Frutos V
Endocrinol Nutr; 2010 Dec; 57(10):504-6. PubMed ID: 20951655
[No Abstract] [Full Text] [Related]
9. Parathyroid carcinoma: a case with recurrence treated with extensive vascular surgery to the neck.
Qvist N; Krøll L; Ladefoged C; Blichert-Toft M; Rohr N
Eur J Surg Oncol; 1986 Jun; 12(2):187-91. PubMed ID: 3011517
[TBL] [Abstract][Full Text] [Related]
10. Recurrent parathyroid carcinoma appearing as FDG negative but MIBI positive.
Alabed YZ; Rakheja R; Novales-Diaz JA; Lisbona R
Clin Nucl Med; 2014 Jul; 39(7):e362-4. PubMed ID: 24458176
[TBL] [Abstract][Full Text] [Related]
11. Preoperative detection of parathyroid adenomas with Tc-99m MIBI and Tc-99m pertechnetate scintigraphy: histopathological and biochemical correlation with Tc-99m MIBI uptake.
Akin M; Atasever T; Kurukahvecioglu O; Dogan M; Gokaslan D; Poyraz A; Koksal H; Taneri F
Bratisl Lek Listy; 2009; 110(3):166-9. PubMed ID: 19507637
[TBL] [Abstract][Full Text] [Related]
12. Parathyroid 99mTc-sestamibi scintigraphy: dual-tracer subtraction is superior to double-phase washout.
Leslie WD; Dupont JO; Bybel B; Riese KT
Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1566-70. PubMed ID: 12458389
[TBL] [Abstract][Full Text] [Related]
13. [Use of SPECT with (99m)Tc-Sestamibi in a patient affected by laryngeal carcinoma and parathyroid adenoma].
Giordano A; Galli J; Corina L; Samanes Gajate AM; D'Andrea G; Almadori G
Rev Esp Med Nucl; 2000 Jun; 19(3):211-4. PubMed ID: 11062085
[TBL] [Abstract][Full Text] [Related]
14. Delayed tc-99m sestamibi washout in graves' disease.
Balan KK; Baltrop AH; Wishart GC
Clin Nucl Med; 2003 Mar; 28(3):239-40. PubMed ID: 12592140
[No Abstract] [Full Text] [Related]
15. Technetium Tc 99m sestamibi sensitivity in oxyphil cell-dominant parathyroid adenomas.
Bleier BS; LiVolsi VA; Chalian AA; Gimotty PA; Botbyl JD; Weber RS
Arch Otolaryngol Head Neck Surg; 2006 Jul; 132(7):779-82. PubMed ID: 16847189
[TBL] [Abstract][Full Text] [Related]
16. [Localization of parathyroid adenomas].
Mjåland O; Normann E; Halvorsen E; Rynning S
Tidsskr Nor Laegeforen; 2003 Mar; 123(5):648-50. PubMed ID: 12683196
[No Abstract] [Full Text] [Related]
17. Concurrent papillary thyroid cancer and parathyroid adenoma as a rare condition: a case report.
Javadi H; Jallalat S; Farrokhi S; Semnani S; Mogharrabi M; Riazi A; Nabipour I; Moshtaghi D; Assadi M
Nucl Med Rev Cent East Eur; 2012 Aug; 15(2):153-5. PubMed ID: 22936512
[TBL] [Abstract][Full Text] [Related]
18. Technetium-99m-sestamibi uptake by recurrent Hurthle cell carcinoma of the thyroid.
Balon HR; Fink-BennetT D; Stoffer SS
J Nucl Med; 1992 Jul; 33(7):1393-5. PubMed ID: 1535374
[TBL] [Abstract][Full Text] [Related]
19. Parathyroid carcinoma. Report of three cases.
Stavraka-Kakavaki A; Fronistas O; Toumbouros M; Manolas C
Clin Nucl Med; 1992 Jan; 17(1):1-3. PubMed ID: 1311997
[TBL] [Abstract][Full Text] [Related]
20. Application of artificial neural network algorithm to detection of parathyroid adenoma.
Stefaniak B; Cholewiński W; Tarkowska A
Nucl Med Rev Cent East Eur; 2003; 6(2):111-7. PubMed ID: 14737724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
